Samsara Vision

Samsara Vision, Inc. is a privately held specialty medical device company focused on bringing vision and freedom back to late-stage AMD patients. The company is engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies. Their lead product, the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), is the first FDA-approved implantable medical device demonstrated to improve vision and quality of life in individuals with end-stage age-related macular degeneration (AMD), which is the leading cause of blindness in older Americans. Founded in 2015, Samsara Vision aims to significantly improve the quality of life for individuals with untreatable retinal disorders. Their goal is to help patients reconnect to the things in life they love to see and do. The company operates in the industries of Manufacturing and Marketing. Samsara Vision plans to establish a high level of collaboration with healthcare providers through a broad range of direct support programs and services to achieve their goal. Although specific details regarding recent investments and investors are not available, the company's mission and innovative approach in addressing a critical health issue position it as an intriguing potential investment opportunity for venture capitalists.